Displaying drugs 4826 - 4850 of 5888 in total
6-fluoro-9-methyl-9H-pyrido(3,4-B)-indole
Investigational
Nifurpirinol
Experimental
Vet approved
Indotecan
Investigational
Alminoprofen
Alminoprofen is a non-steroidal anti-inflammatory drug (NSAID) whose physiochemical characteristics make it a member of the phenylpropionic acid class of chemical substances.
Experimental
Tolebrutinib
Investigational
Anise oil
Experimental
PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE
Experimental
INO-4995
INO-4995 is an inositol tetrakisphosphate analog being investigated for Cystic Fibrosis.
Investigational
NP-10679
Investigational
Cyclic GMP
Cyclic guanosine monophosphate (Cyclic GMP) is a guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones,...
Experimental
Matched Description: … hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein …
AG0301-COVID19
AG0301-COVID19 is a vaccine candidate developed by AnGes Inc. and Osaka University. The candidate is a plasmid DNA vaccine developed using an intradermal gene transfer method targeting the SARS-CoV-2 spike protein. The gene transfer method increases the efficiency of gene expression and antibody production capability, garnering a more efficient DNA...
Investigational
Matched Description: … plasmid DNA vaccine developed using an intradermal gene transfer method targeting the SARS-CoV-2 spike protein …
Ganaplacide
Ganaplacide is under investigation in clinical trial NCT03167242 (Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria).
Investigational
SLC-0111
Investigational
3-(cyclohexylamino)propanesulfonic acid
Experimental
GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE
Experimental
Zilurgisertib
Investigational
Tipifarnib
Tipifarnib (R-115777) is a substance that is being studied in the treatment of acute myeloid leukemia (AML) and other types of cancer. It belongs to the family of drugs called farnesyltransferase inhibitors. It is also called Zarnestra. In June 2005, the FDA issued a Not Approvable Letter for Zarnestra.
Investigational
5-(2-NITROPHENYL)-2-FUROIC ACID
Experimental
Fosgemcitabine palabenamide
NUC-1031 is under investigation in clinical trial NCT03610100 (Acelarin First Line Randomised Pancreatic Study).
Investigational
Hadacidin
Experimental
STM-217
Investigational
Displaying drugs 4826 - 4850 of 5888 in total